Status: Recruiting
Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease
This study aims to evaluate the effect of angiotensin receptor/neprilysin inhibitors (ARNI) on improving ischemic mitral regurgitation (IMR) in patients with coronary artery disease undergoing isolated coronary artery bypass grafting (CABG) through a randomized controlled clincial trial.
Participants needed: 220
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: China National Center for Cardiovascular DiseasesUpdated: Aug 27, 2025Locations: 1
Eligibility criteria
Fully informed and voluntarily signed informed consent; [+1]